Crystal Girod, MSc, of Beckman Coulter Life Sciences discusses recent developments in NGS and their impact on clinical diagnostics.
Tackling the challenges of “forever chemicals” in the diagnostics industry.
Health inequities and disrupted STI testing and care during the pandemic continued to contribute to a rise in cases in 2021.
Recently released NGS systems will be helpful to researchers but are unlikely to immediately impact diagnostics, expert says.
Leanne Davey of Waters Corporation discusses recent technological trends in the clinical space with G2 managing editor Rachel Muenz.